1.9(top 20%)
impact factor
144(top 100%)
papers
746(top 50%)
citations
13(top 50%)
h-index
2.0(top 20%)
extended IF
158
all documents
848
doc citations
22(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics dataCardiovascular Endocrinology and Metabolism202088
2Development of clinical trials to extend healthy lifespanCardiovascular Endocrinology and Metabolism201859
3Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a reviewCardiovascular Endocrinology and Metabolism201944
4Pathophysiology of cardiovascular disease in diabetes mellitusCardiovascular Endocrinology and Metabolism201835
5Obese communities among the best predictors of COVID-19-related deathsCardiovascular Endocrinology and Metabolism202026
6The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysisCardiovascular Endocrinology and Metabolism202125
7Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass indexCardiovascular Endocrinology and Metabolism201922
8Cardiovascular disease in type 1 diabetesCardiovascular Endocrinology and Metabolism201922
9Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medicationsCardiovascular Endocrinology and Metabolism202020
10Cardiometabolic disease in the older person: prediction and prevention for the generalist physicianCardiovascular Endocrinology and Metabolism202019
11The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about itCardiovascular Endocrinology and Metabolism201918
12Vascular disease in the lower limb in type 1 diabetesCardiovascular Endocrinology and Metabolism201916
13Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetesCardiovascular Endocrinology and Metabolism202016
14Coronary microvascular disease: current concepts of pathophysiology, diagnosis and managementCardiovascular Endocrinology and Metabolism202116
15Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?Cardiovascular Endocrinology and Metabolism202015
16Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunitiesCardiovascular Endocrinology and Metabolism202014
17The acute vs. chronic effect of exercise on insulin sensitivity: nothing lasts foreverCardiovascular Endocrinology and Metabolism202114
18Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyondCardiovascular Endocrinology and Metabolism202113
19Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19Cardiovascular Endocrinology and Metabolism202012
20Cardiometabolic medicine – the US perspective on a new subspecialtyCardiovascular Endocrinology and Metabolism202012
21The epidemiological status, environmental and genetic factors in the etiology of Keshan diseaseCardiovascular Endocrinology and Metabolism202112
22Cardioprotective diabetes drugs: what cardiologists need to knowCardiovascular Endocrinology and Metabolism201911
23Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort studyCardiovascular Endocrinology and Metabolism202111
24The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular diseaseCardiovascular Endocrinology and Metabolism201810
25Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications studyCardiovascular Endocrinology and Metabolism201910
26Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetesCardiovascular Endocrinology and Metabolism201910
27Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortalityCardiovascular Endocrinology and Metabolism20209
28Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complicationsCardiovascular Endocrinology and Metabolism20209
29Effects of aerobic and anaerobic exercise on glucose tolerance in patients with coronary heart disease and type 2 diabetes mellitusCardiovascular Endocrinology and Metabolism20209
30The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategiesCardiovascular Endocrinology and Metabolism20219
31Cardiometabolic medicine: time to recognize a new clinical specialty?Cardiovascular Endocrinology and Metabolism20198
32The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UKCardiovascular Endocrinology and Metabolism20208
33Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19Cardiovascular Endocrinology and Metabolism20208
34A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination SurveyCardiovascular Endocrinology and Metabolism20208
35Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptomsCardiovascular Endocrinology and Metabolism20208
36Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of PakistanCardiovascular Endocrinology and Metabolism20208
37Exercise, cancer and cardiovascular disease: what should clinicians advise?Cardiovascular Endocrinology and Metabolism20218
38Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarctionCardiovascular Endocrinology and Metabolism20206
39Cardioprotective glucose-lowering medications: evidence and uncertainties in a new therapeutic eraCardiovascular Endocrinology and Metabolism20185
40Diagnostic challenges in supraventricular tachycardia: anticipating value of natriuretic peptidesCardiovascular Endocrinology and Metabolism20185
41Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologistsCardiovascular Endocrinology and Metabolism20205
42Exercise prescription in patients with type 2 diabetes and coronary heart disease: could less be more?Cardiovascular Endocrinology and Metabolism20205
43Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitusCardiovascular Endocrinology and Metabolism20205
44Vitamin D status in acute myocardial infarction: a case–control studyCardiovascular Endocrinology and Metabolism20184
45Interaction between cardiovascular autonomic control and sex hormones in perimenopausal women under menopausal hormone therapyCardiovascular Endocrinology and Metabolism20184
46Serum leptin in male hypothyroid prediabetic patients: Association with cardiovascular riskCardiovascular Endocrinology and Metabolism20184
47Milk and dairy foods: implications for cardiometabolic healthCardiovascular Endocrinology and Metabolism20184
48Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarctionCardiovascular Endocrinology and Metabolism20194
49Vascular disease and type 2 diabetes: the science policy case for early cardiometabolic interventionCardiovascular Endocrinology and Metabolism20194
50Type 1 diabetes mellitus and coronary revascularizationCardiovascular Endocrinology and Metabolism20194